Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Colorcon
Covington
Harvard Business School
Argus Health
Medtronic
Cerilliant
Fish and Richardson
Teva
McKesson

Generated: June 21, 2018

DrugPatentWatch Database Preview

PAMINE Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Pamine, and when can generic versions of Pamine launch?

Pamine is a drug marketed by Fougera Pharms and is included in one NDA.

The generic ingredient in PAMINE is methscopolamine bromide. There are seven drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the methscopolamine bromide profile page.
Drug patent expirations by year for PAMINE
Pharmacology for PAMINE
Drug ClassAnticholinergic
Mechanism of ActionCholinergic Antagonists
Synonyms for PAMINE
(-)-(1S,3s,5R,6R,7S)-6,7-epoxy-8-methyl-3-[(S)-tropoyloxy]tropanium bromide
(-)-scopolamine methobromide
(-)-Scopolamine methyl bromide
(-)-Scopolamine methyl bromide, >=98% (HPLC), powder
(-)-Tropate(ester)
(1R,2R,4S,5S,7s)-7-(((S)-3-hydroxy-2-phenylpropanoyl)oxy)-9,9-dimethyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium bromide
(1R,2R,4S,5S,7s)-7-[[(2S)-3-Hydroxy-2-phenylpropanoyl]oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane Bromide (Methylhyoscine Bromide)
(1R,2R,4S,5S,7s)-7-[[(2S)-3-Hydroxy-2-phenylpropanoyl]oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane bromide
(1R,2R,4S,5S,7S)-7-{[(2S)-3-hydroxy-2-phenylpropanoyl]oxy}-9,9-dimethyl-3-oxa-9-azatricyclo[3.3.1.0^{2,4}]nonan-9-ium bromide
(1R,2R,4S,5S,7s)-7-{[(2S)-3-hydroxy-2-phenylpropanoyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.0(2,4)]nonane
(1R,2R,4S,5S,7S)-7-{[(2S)-3-hydroxy-2-phenylpropanoyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane bromidebromide
(1R,2R,4S,5S)-7-{[(2S)-3-hydroxy-2-phenylpropanoyl]oxy}-9,9-dimethyl-3-oxa-9-azatricyclo[3.3.1.0^{2,4}]nonan-9-ium
(1r,2r,4s,5s)-7-{[(2s)-3-hydroxy-2-phenylpropanoyl]oxy}-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane
(1S,2R,4S,5S)-7-((3-hydroxy-2-phenylpropanoyl)oxy)-9,9-dimethyl-3-oxa-9-azatricyclo[3.3.1.02,4]nonan-9-ium bromide
(1S,2R,4S,5S)-7-[(3-HYDROXY-2-PHENYLPROPANOYL)OXY]-9,9-DIMETHYL-3-OXA-9-AZATRICYCLO[3.3.1.0(2),?]NONAN-9-IUM BROMIDE
(1s,2r,4s,5s)-7-[(3-hydroxy-2-phenylpropanoyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane bromide
(1S,5S,7R)-7-{[(2S)-3-hydroxy-2-phenylpropanoyl]oxy}-9,9-dimethyl-3-oxa-9-azatricyclo[3.3.1.0^{2,4}]nonan-9-ium bromide
(1S,5S,7R)-7-{[(2S)-3-hydroxy-2-phenylpropanoyl]oxy}-9,9-dimethyl-3-oxa-9-azatricyclo[3.3.1.0;{2,4}]nonan-9-ium bromide
(S)-6beta,7beta-Epoxy-8-methyl-3alpha-(-)-tropoyloxy-1alphaH,5alphaH-tromanium bromide
[3H]N-methyl scopolamine
[3H]N-methylscopolamine
[3H]NMS
1-alpha-H,5-alpha-H-Tropanium, 6-beta,7-beta-epoxy-3-alpha-hydroxy-8-methyl-, bromide, (-)-tropate (ester)
1-alpha-H,5-alpha-H-Tropanium, 6-beta,7-beta-epoxy-3-alpha-hydroxy-8-methyl-, bromide,(-)-tropate (ester)
1-alpha-H,5-alpha-H-Tropanium,6-beta,7-beta-epoxy-3-alpha-hydroxy-8-methyl-, bromide, (-)-tropate (ester)
1.alpha.-H, 6.beta.,7.beta.-epoxy-3.alpha.-hydroxy-8-methyl-, bromide, (-)-tropate
1.alpha.H, 6.beta.,7.beta.-epoxy-3.alpha.-hydroxy-8-methyl-, bromide, (-)-tropate
13265-10-6
13265-10-6 (Parent)
1420-31-1
155-41-9
155-41-9 (Bromide)
18067-13-5 (Methylsulfate)
18905-44-7
1alphaH,5alphaH-Tropanium, 6beta,7beta-epoxy-3alpha-hydroxy-8-methyl-, bromide, (-)-tropate
1alphaH,5alphaH-Tropanium, 6beta,7beta-epoxy-3alpha-hydroxy-8-methyl-, bromide, (-)-tropate (8CI)
2660-04-0
3-[(2-Phenyl-3-hydroxy-1-oxopropyl)oxy]-8,8-dimethyl-6,7-epoxy-8-azoniabicyclo[3.2.1]octane
3-Oxa-9-azoniatricyclo(3.3.1.0(2,4))nonane, 7-(3-hydroxy-1-oxo-2-phenylpropoxy)-9,9-dimethyl-, (7(S)-(1alpha,2beta,4beta,5alpha,7beta))-
3-Oxa-9-azoniatricyclo(3.3.1.0(sup 2,4))nonane, 7-(3-hydroxy-1-oxo-2-phenylpropoxy)-9,9-dimethyl-, bromide, (7(S)-(1alpha,2beta,4beta,5alpha,7beta))-
3-Oxa-9-azoniatricyclo(3.3.1.02,4)nonane, 7-((2S)-3-hydroxy-1-oxo-2-phenylpropoxy)-9,9-dimethyl-, bromide (1:1), (1alpha,2beta,4beta,5alpha,7beta)-
3-Oxa-9-azoniatricyclo(3.3.1.02,4)nonane, 7-((2S)-3-hydroxy-1-oxo-2-phenylpropoxy)-9,9-dimethyl-, bromide, (1alpha,2beta,4beta,5alpha,7beta)-
3-Oxa-9-azoniatricyclo[3.3.1.02, 7-(3-hydroxy-1-oxo-2-phenylpropoxy)-9,9-dimethyl-, bromide, [7(S)-(1.alpha.,2.beta.,4.beta.,5.alpha.,7.beta.)]-
3-Oxa-9-azoniatricyclo[3.3.1.02,4]nonane, 7-[(2S)-3-hydroxy-1-oxo-2-phenylpropoxy]-9,9-dimethyl-, (1a,2b,4b,5a,7b)
3C0
52211-64-0
53832-46-5
56552-70-6
6106-46-3 (Nitrate)
6beta,7beta-Epoxy-3alpha-hydroxy-8-methyl-1alphaH,5alphaH-tropanium bromide (-)-tropate
7-(3-Hydroxy-1-oxo-2-phenylpropoxy)-9,9-dimethyl-3-oxo-9-azoniatricyclo-(3.3.1.0(2,4))nonane bromide
7-(3-Hydroxy-2-phenyl-propionyloxy)-9,9-dimethyl-3-oxa-9-azonia-tricyclo[3.3.1.0*2,4*]nonane
7-(3-Hydroxy-2-phenyl-propionyloxy)-9,9-dimethyl-3-oxa-9-azonia-tricyclo[3.3.1.0*2,4*]nonane; bromide(scopolamine methyl bromide)
7-[(3-hydroxy-2-phenylpropanoyl)oxy]-9,9-dimethyl-3-oxa-9-azoniatricyclo[3.3.1.02,4]nonane
9,9-dimethyl-3-oxa-95-azatricyclo[3.3.1.0~2,4~]non-7-yl tropate
AB00385828_19
AB2000400
AC1L1HGG
AC1L1S97
AC1Q1R9E
AC1Q1RGR
AC1Q60OB
AKOS026749843
AKOS030524090
Ampyrox
API0004143
BDBM214800
BDBM50015727
BDBM50241132
Blocan
C18H24NO4.HBr
CAS-155-41-9
CHEBI:135361
CHEBI:61276
CHEBI:6845
CHEMBL107979
CHEMBL1354199
CHEMBL293927
CHEMBL3091667
CHEMBL3140030
CHEMBL376897
CS-2386
CTK4F8213
CTK5A5327
CTK8A1520
D00715
D04LHJ
D0M6VK
D0S6SF
Daipin
DB00462
DB11315
Diopal
DSSTox_CID_20608
DSSTox_GSID_40608
DSSTox_RID_79509
DTXSID0046931
DTXSID2040608
EC 205-844-5
EINECS 205-844-5
Epoxymethamine bromide
Epoxytropine tropate methylbromide
GTPL316
GTPL317
HE019761
HMS2235K24
Holopon
HSDB 5420
HY-B0344
Hyoscin methobromide
Hyoscin-N-methylbromid
Hyoscine Methobromide
Hyoscine methobromide (INN)
Hyoscine methyl bromide
Hyoscine methylbromide
L001039
Lescopine bromide
LS-157838
LS-187066
LS-187674
MCULE-9148232132
Mescopil
Methoscopylamine bromide
methscopolamine
Methscopolamine (bromide)
Methscopolamine (Pamine)
METHSCOPOLAMINE BROMIDE
Methscopolamine bromide (USP)
Methscopolamine bromide [USP]
Methscopolamine bromide, United States Pharmacopeia (USP) Reference Standard
Methscopolamine methylbromide
Methyl scopolamine
Methylhyoscine Bromide (Methscopolamine Bromide)
Methylscopolamine
Methylscopolamine bromide
Methylscopolamine hydrobromide
Metylskopolamin
MFCD00078560
MLS000069754
MolPort-016-633-266
N-methyl scopolamine
N-Methylhyoscine
N-Methylhyoscine bromide
N-Methylhyoscinium bromide
N-Methylscopolamine
N-methylscopolamine (NMS)
N-Methylscopolamine Bromide
n-methylscopolamine methylsulfate
N-Methylscopolammonium bromide
NCGC00013724-01
NCGC00022697-03
NCGC00162342-01
NCGC00162342-02
Neo-Avagal
NMS
NSC 120606
NSC-120606
NSC-61809
NSC120606
NSC61809
Nutrop
Opera_ID_514
Oxitropium bromide impurity B, European Pharmacopoeia (EP) Reference Standard
Pamine (TN)
Pamine Bromide
Pamine Forte
Paraspan
PDSP2_000640
PL044589
Proscomide
Restropin
RTN51LK7WL
s1978
SCHEMBL152483
SCHEMBL158622
SCHEMBL1652312
SCHEMBL65398
Scopolamin methylbromide
Scopolamin-N-methylbromid
Scopolamine methobromide
scopolamine methyl bromide
Scopolamine methyl bromide;Pamine
Scopolamine methylbromide
Scopolammonium, bromide
Scopolammonium, N-methyl-, bromide
SCOPOLAMMONIUM, N-METHYLBROMIDE
Scordin
SMR000058794
Tox21_110037
Tox21_110037_1
U 0382
UNII-RTN51LK7WL
UNII-VDR09VTQ8U
VDR09VTQ8U
W-108020
WLN: T C356 A AK DOTJ A1 A1 HOVYR & 1Q & Q & E
ZINC100047524

US Patents and Regulatory Information for PAMINE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Fougera Pharms PAMINE methscopolamine bromide TABLET;ORAL 008848-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Fougera Pharms PAMINE FORTE methscopolamine bromide TABLET;ORAL 008848-002 Mar 25, 2003 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Express Scripts
Merck
Federal Trade Commission
Fuji
Cantor Fitzgerald
Johnson and Johnson
AstraZeneca
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.